Lantheus Holdings, Inc. (LNTH) Form 10-K Annual Reports
Lantheus Holdings, Inc. (LNTH) is a publicly traded company on the Nasdaq, categorized under SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LNTH
CIK: 1521036
Exchange: Nasdaq
SIC 2835: In Vitro & In Vivo Diagnostic Substances
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerKevin Gauthier
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-14 | 2026-10-14 | 8-K | 0001193125-26-421732 | View SEC Doc Filr Page |
| DEFA14A | 2026-10-02 | — | DEFA14A | 0001193125-26-412567 | View SEC Doc Filr Page |
| 8-K | 2026-10-02 | 2026-10-02 | 8-K | 0001193125-26-412563 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-23 | — | SCHEDULE 13D/A Filing | 0001193125-26-399446 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-21 | — | DEFA14A | 0001193125-26-396661 | View SEC Doc Filr Page |
| 8-K | 2026-09-21 | 2026-09-17 | 8-K | 0001193125-26-396654 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-17 | — | DEFA14A | 0001193125-26-393460 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-03 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000318 | View SEC Doc Filr Page |
| DEFM14A | 2026-09-08 | — | DEFM14A | 0001193125-26-384284 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000316 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-04 | — | SCHEDULE 13D/A Filing | 0001193125-26-383775 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-04 | — | SCHEDULE 13G Filing | 0001193125-26-383762 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-09-04 | — | SCHEDULE 13D Filing | 0001193125-26-383754 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000310 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000308 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000307 | View SEC Doc Filr Page |
| S-8 | 2026-09-02 | — | S-8 | 0001193125-26-379372 | View SEC Doc Filr Page |
| PREM14A | 2026-08-26 | 2026-08-26 | PREM14A | 0001193125-26-365886 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000278 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000277 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-13 | — | DEFA14A | 0001193125-26-349639 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0000908834-26-000401 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-336795 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-336771 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-04 | — | DEFA14A | 0001193125-26-332873 | View SEC Doc Filr Page |